Cyanine–Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells
Author:
Affiliation:
1. Department of Chemistry, Texas A&M University, Box 30012, College Station, Texas 77842, United States
2. Department of Molecular & Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas 77843, United States
Funder
Division of Chemistry
Welch Foundation
National Eye Institute
Texas A and M University
U.S. Department of Defense
Cancer Prevention and Research Institute of Texas
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b01147
Reference38 articles.
1. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study
2. Food and Drug Administration Drug Approval Summary: Temozolomide Plus Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
3. Glioblastoma: Overview of Disease and Treatment
4. Gemcitabine and glioblastoma: challenges and current perspectives
5. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitochondria-targeting near-infrared (NIR) materials orchestrating the symphony of precision diagnosis and therapy;Nano Today;2024-12
2. Repurposing gemcitabine for glioblastoma treatment: The role of drug-conjugates and nanoparticles as drug delivery systems;Journal of Drug Delivery Science and Technology;2024-06
3. Photothermally driven degradable nanomissile for single-wavelength phototherapy and hypoxia-activated chemotherapy;Inorganic Chemistry Communications;2023-11
4. Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent;ACS Applied Materials & Interfaces;2023-09-15
5. Development of Iodinated Indocyanine Green Analogs as a Strategy for Targeted Therapy of Liver Cancer;ACS Medicinal Chemistry Letters;2023-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3